Ecraid
@ecraid.bsky.social
The European Clinical Research Alliance for Infectious Diseases is a not-for profit foundation that advances clinical research in infectious diseases.
As we close out 2025, we look back on a truly landmark year for Ecraid: one defined by growth, collaboration, and impact. Thank you to our partners, collaborators, sites, investigators, and team members for your commitment and trust.
Happy holidays, and all the best for the year ahead 🌟
Happy holidays, and all the best for the year ahead 🌟
December 24, 2025 at 9:02 AM
As we close out 2025, we look back on a truly landmark year for Ecraid: one defined by growth, collaboration, and impact. Thank you to our partners, collaborators, sites, investigators, and team members for your commitment and trust.
Happy holidays, and all the best for the year ahead 🌟
Happy holidays, and all the best for the year ahead 🌟
🎉 Amazing milestones reached in three of our perpetual observational studies (POS)! We are tremendously proud of ALL the site teams behind these studies, for making it happen as 2025 comes to an end - a great way to wrap up the year!
Thank you!
ecraid.eu/ecraid-base/...
Thank you!
ecraid.eu/ecraid-base/...
December 23, 2025 at 9:30 AM
🎉 Amazing milestones reached in three of our perpetual observational studies (POS)! We are tremendously proud of ALL the site teams behind these studies, for making it happen as 2025 comes to an end - a great way to wrap up the year!
Thank you!
ecraid.eu/ecraid-base/...
Thank you!
ecraid.eu/ecraid-base/...
📩Our final newsletter of 2025 is out!
As we close 2025, we also say farewell to our CEO, @marcbonten.bsky.social. We are proud of what we have achieved together over the years & look ahead with confidence to 2026, welcoming @lenniederde.bsky.social onboard!
Read more & subscribe: bit.ly/Dec25Ecraid
As we close 2025, we also say farewell to our CEO, @marcbonten.bsky.social. We are proud of what we have achieved together over the years & look ahead with confidence to 2026, welcoming @lenniederde.bsky.social onboard!
Read more & subscribe: bit.ly/Dec25Ecraid
December 18, 2025 at 1:18 PM
📩Our final newsletter of 2025 is out!
As we close 2025, we also say farewell to our CEO, @marcbonten.bsky.social. We are proud of what we have achieved together over the years & look ahead with confidence to 2026, welcoming @lenniederde.bsky.social onboard!
Read more & subscribe: bit.ly/Dec25Ecraid
As we close 2025, we also say farewell to our CEO, @marcbonten.bsky.social. We are proud of what we have achieved together over the years & look ahead with confidence to 2026, welcoming @lenniederde.bsky.social onboard!
Read more & subscribe: bit.ly/Dec25Ecraid
Trainings, talent & top science: the last Ecraid Learning Newsletter of the year is out!
Filled to the brim with exciting courses, testimonials from participants at past ones, freshly-published science and interesting interviews & blogs!
👉🏽https://bit.ly/LearningDecEcraid
Filled to the brim with exciting courses, testimonials from participants at past ones, freshly-published science and interesting interviews & blogs!
👉🏽https://bit.ly/LearningDecEcraid
December 15, 2025 at 9:48 AM
Trainings, talent & top science: the last Ecraid Learning Newsletter of the year is out!
Filled to the brim with exciting courses, testimonials from participants at past ones, freshly-published science and interesting interviews & blogs!
👉🏽https://bit.ly/LearningDecEcraid
Filled to the brim with exciting courses, testimonials from participants at past ones, freshly-published science and interesting interviews & blogs!
👉🏽https://bit.ly/LearningDecEcraid
📩 Our latest newsletter is out! We’re thrilled to welcome our new CEO, @lenniederde.bsky.social, marking a fresh chapter in Ecraid’s journey. Other updates in this edition:
✅ ECRAID-Base: new publications
✅ ECRAID-Prime: launch of third treatment arm
And more…
📫 Subscribe now: bit.ly/NovEcraid
✅ ECRAID-Base: new publications
✅ ECRAID-Prime: launch of third treatment arm
And more…
📫 Subscribe now: bit.ly/NovEcraid
November 13, 2025 at 1:31 PM
📩 Our latest newsletter is out! We’re thrilled to welcome our new CEO, @lenniederde.bsky.social, marking a fresh chapter in Ecraid’s journey. Other updates in this edition:
✅ ECRAID-Base: new publications
✅ ECRAID-Prime: launch of third treatment arm
And more…
📫 Subscribe now: bit.ly/NovEcraid
✅ ECRAID-Base: new publications
✅ ECRAID-Prime: launch of third treatment arm
And more…
📫 Subscribe now: bit.ly/NovEcraid
📩 Our latest newsletter is out!
Discover significant developments at Ecraid, including the launch of our new campaign to foster strategic collaborations, #PartnerForImpact!
📫 Stay informed, subscribe now bit.ly/43kBWhJ
#PartnerWithEcraid #ClinicalResearch #InfectiousDiseases #Education #Knowledge
Discover significant developments at Ecraid, including the launch of our new campaign to foster strategic collaborations, #PartnerForImpact!
📫 Stay informed, subscribe now bit.ly/43kBWhJ
#PartnerWithEcraid #ClinicalResearch #InfectiousDiseases #Education #Knowledge
October 14, 2025 at 10:54 AM
📩 Our latest newsletter is out!
Discover significant developments at Ecraid, including the launch of our new campaign to foster strategic collaborations, #PartnerForImpact!
📫 Stay informed, subscribe now bit.ly/43kBWhJ
#PartnerWithEcraid #ClinicalResearch #InfectiousDiseases #Education #Knowledge
Discover significant developments at Ecraid, including the launch of our new campaign to foster strategic collaborations, #PartnerForImpact!
📫 Stay informed, subscribe now bit.ly/43kBWhJ
#PartnerWithEcraid #ClinicalResearch #InfectiousDiseases #Education #Knowledge
📩 In our latest newsletter you can read more about Ecraid’s September highlights including studies updates and other milestones!
👉🏽 Meet us in Amsterdam at the ERS Congress & World Vaccine Congress. Book a meeting with our team: [email protected]
📫 Stay informed, subscribe now: bit.ly/EcraidNewsSe...
👉🏽 Meet us in Amsterdam at the ERS Congress & World Vaccine Congress. Book a meeting with our team: [email protected]
📫 Stay informed, subscribe now: bit.ly/EcraidNewsSe...
September 15, 2025 at 9:40 AM
📩 In our latest newsletter you can read more about Ecraid’s September highlights including studies updates and other milestones!
👉🏽 Meet us in Amsterdam at the ERS Congress & World Vaccine Congress. Book a meeting with our team: [email protected]
📫 Stay informed, subscribe now: bit.ly/EcraidNewsSe...
👉🏽 Meet us in Amsterdam at the ERS Congress & World Vaccine Congress. Book a meeting with our team: [email protected]
📫 Stay informed, subscribe now: bit.ly/EcraidNewsSe...
📩In our latest newsletter you can read more about our upcoming educational opportunities and get the latest updates on publications and study milestones.
👉🏽We're hiring a Chief Executive Officer! Are you interested? Read more in our newsletter.
📫Stay informed, subscribe now: bit.ly/07NewsEcraid
👉🏽We're hiring a Chief Executive Officer! Are you interested? Read more in our newsletter.
📫Stay informed, subscribe now: bit.ly/07NewsEcraid
July 8, 2025 at 12:53 PM
📩In our latest newsletter you can read more about our upcoming educational opportunities and get the latest updates on publications and study milestones.
👉🏽We're hiring a Chief Executive Officer! Are you interested? Read more in our newsletter.
📫Stay informed, subscribe now: bit.ly/07NewsEcraid
👉🏽We're hiring a Chief Executive Officer! Are you interested? Read more in our newsletter.
📫Stay informed, subscribe now: bit.ly/07NewsEcraid